In the past week, CERT stock has gone up by 7.76%, with a monthly gain of 1.41% and a quarterly surge of 16.36%. The volatility ratio for the week is 4.62%, and the volatility levels for the last 30 days are 4.58% for Certara Inc The simple moving average for the last 20 days is 2.19% for CERT stock, with a simple moving average of -0.32% for the last 200 days.
Is It Worth Investing in Certara Inc (NASDAQ: CERT) Right Now?
Moreover, the 36-month beta value for CERT is 1.44. Analysts have varying opinions on the stock, with 4 analysts rating it as a “buy,” 1 as “overweight,” 6 as “hold,” and 0 as “sell.”
The public float for CERT is 119.58M and currently, short sellers hold a 7.49% of that float. On July 02, 2025, CERT’s average trading volume was 2.20M shares.
CERT) stock’s latest price update
Certara Inc (NASDAQ: CERT) has seen a decline in its stock price by -1.54 in relation to its previous close of 11.7. However, the company has experienced a 7.76% gain in its stock price over the last five trading sessions. fool.com reported 2025-06-28 that There’s a strong case that healthcare is the most important sector in the stock market. These companies deliver innovative therapies and medical technologies that are often life-saving.
Analysts’ Opinion of CERT
Many brokerage firms have already submitted their reports for CERT stocks, with Barclays repeating the rating for CERT by listing it as a “Overweight.” The predicted price for CERT in the upcoming period, according to Barclays is $14 based on the research report published on May 08, 2025 of the current year 2025.
TD Cowen, on the other hand, stated in their research note that they expect to see CERT reach a price target of $16. The rating they have provided for CERT stocks is “Buy” according to the report published on February 27th, 2025.
UBS gave a rating of “Buy” to CERT, setting the target price at $16 in the report published on September 27th of the previous year.
CERT Trading at -3.70% from the 50-Day Moving Average
After a stumble in the market that brought CERT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -31.96% of loss for the given period.
Insider Trading
SMITH PATRICK F, the PRESIDENT, DRUG DEV SOLUTIONS of Certara Inc, sale 5,409 shares at $11.03 during a trade that took place back on Oct 07 ’24, which means that SMITH PATRICK F is holding 50,091 shares at $59,661 based on the most recent closing price.
Stock Fundamentals for CERT
Current profitability levels for the company are sitting at:
- 0.03 for the present operating margin
- 0.57 for the gross margin
The net margin for Certara Inc stands at -0.01. The total capital return value is set at 0.01. Equity return is now at value -0.25, with -0.17 for asset returns.
Based on Certara Inc (CERT), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 7.29. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is 1.2.
Currently, EBITDA for the company is 72.37 million with net debt to EBITDA at -5.63. When we switch over and look at the enterprise to sales, we see a ratio of 4.32. The receivables turnover for the company is 4.22for trailing twelve months and the total asset turnover is 0.25. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.78.
Conclusion
To wrap up, the performance of Certara Inc (CERT) has been better in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
